Eur Rev Med Pharmacol Sci 2018; 22 (16): 5200-5205DOI: 10.26355/eurrev_201808_15717 CD34, PCNA and CK19 expressions in AFP– hepatocellular carcinoma D.-J. Cui, Y. Wu, D.-H. Wen Free PDF Download
Eur Rev Med Pharmacol Sci 2018; 22 (16): 5194-5199DOI: 10.26355/eurrev_201808_15716 Investigation of PD-1H in DEN-induced mouse liver cancer model C.-J. Lei, B. Wang, Z.-X. Long, H. Ren, Q.-Y. Pan, Y. Li Free PDF Download
Eur Rev Med Pharmacol Sci 2018; 22 (16): 5187-5193DOI: 10.26355/eurrev_201808_15715 Serum miR-629 is a novel molecular marker for diagnosis and the prognosis of pancreatic cancer W. Shi, Y. Lu, R. Gong, J.-J. Sun, G. Liu Free PDF Download
Eur Rev Med Pharmacol Sci 2018; 22 (16): 5180-5186DOI: 10.26355/eurrev_201808_15714 P3H4 affects renal carcinoma through up-regulating miR-1/133a B. Wan, Q. Zeng, X.-Z. Tang, Y.-X. Tang Free PDF Download
Eur Rev Med Pharmacol Sci 2018; 22 (16): 5172-5179DOI: 10.26355/eurrev_201808_15713 MiR-429 regulates the proliferation and apoptosis of nephroblastoma cells through targeting c-myc H.-F. Wang, W.-H. Wang, H.-W. Zhuang, M. Xu Free PDF Download
Eur Rev Med Pharmacol Sci 2018; 22 (16): 5165-5171DOI: 10.26355/eurrev_201808_15712 The role novel targeted agents in the treatment of previously treated patients with advanced urothelial carcinoma (UC): a meta-analysis X.-K. Li, W.-L. Wang Free PDF Download
Eur Rev Med Pharmacol Sci 2018; 22 (16): 5156-5164DOI: 10.26355/eurrev_201808_15711 MicroRNA-214 functions as an oncogene in human osteosarcoma by targeting TRAF3 A.-L. Rehei, L. Zhang, Y.-X. Fu, W.-B. Mu, D.-S. Yang, Y. Liu, S.-J. Zhou, A. Younusi Free PDF Download
Eur Rev Med Pharmacol Sci 2018; 22 (16): 5149-5155DOI: 10.26355/eurrev_201808_15710 Significance of the Ki-67 proliferation index in the assessment of the therapeutic response to cisplatin-based chemotherapy in patients with advanced cervical cancer D. Krtinic, R. Zivadinovic, Z. Jovic, S. Pesic, D. Mihailovic, L. Ristic, A. Cvetanovic, I. Todorovska, N. Zivkovic, G.N. Rankovic, D. Stokanovic, B. Zivadinovic, M. Trandafilovic, M.A. Apostolovic, M. Golubovic, A. Zivadinovic Free PDF Download
Eur Rev Med Pharmacol Sci 2018; 22 (16): 5140-5148DOI: 10.26355/eurrev_201808_15709 Correlation study between long non-coding RNA MALAT1 and radiotherapy efficiency on cervical carcinoma and generation of radiotherapy resistant model of cancer P. Zhu, F.-Q. Wang, Q.-R. Li Free PDF Download
Eur Rev Med Pharmacol Sci 2018; 22 (16): 5134-5139DOI: 10.26355/eurrev_201808_15708 Protein expressions of AIB1, p53 and Bcl-2 in epithelial ovarian cancer and their correlations with the clinical pathological features and prognosis M. Liang, J. Zhao Free PDF Download
Eur Rev Med Pharmacol Sci 2018; 22 (16): 5127-5133DOI: 10.26355/eurrev_201808_15707 LINC01116 promotes the progression of epithelial ovarian cancer via regulating cell apoptosis Y.-N. Fang, Z.-L. Huang, H. Li, W.-B. Tan, Q.-G. Zhang, L. Wang, J.-L. Wu Free PDF Download
Eur Rev Med Pharmacol Sci 2018; 22 (16): 5053-5055DOI: 10.26355/eurrev_201808_15696 Long non-coding RNAs: possible parallel paths by E-cadherin expression in colon cancer development as well as in Pseudomonas aeruginosa infection A. Scano, G. Orrù, G. Serafi, A. Occhinegro, D. Ratto, C. Girometta, P. Rossi Free PDF Download
Eur Rev Med Pharmacol Sci 2018; 22 (16): 5051-5052DOI: 10.26355/eurrev_201808_15695 MiR-431 inhibits colorectal cancer cell invasion via repressing CUL4B R. Fisichella, A. Cappellani, S. Berretta Free PDF Download
Eur Rev Med Pharmacol Sci 2018; 22 (15): 4925-4933DOI: 10.26355/eurrev_201808_15631 MiR-122 inhibits cell proliferation and induces apoptosis by targeting runt-related transcription factors 2 in human glioma C.-Q. Ding, W.-S. Deng, X.-F. Yin, X.-D. Ding Free PDF Download
Eur Rev Med Pharmacol Sci 2018; 22 (15): 4917-4924DOI: 10.26355/eurrev_201808_15630 Increased expression of long noncoding RNA LINC00961 suppresses glioma metastasis and correlates with favorable prognosis X.-W. Lu, N. Xu, Y.-G. Zheng, Q.-X. Li, J.-S. Shi Free PDF Download
Eur Rev Med Pharmacol Sci 2018; 22 (15): 4908-4916DOI: 10.26355/eurrev_201808_15629 MiR-608 exerts tumor suppressive function in lung adenocarcinoma by directly targeting MIF H.-X. Yu, X.-M. Wang, X.-D. Han, B.-F. Cao Free PDF Download
Eur Rev Med Pharmacol Sci 2018; 22 (15): 4898-4907DOI: 10.26355/eurrev_201808_15626 SOX9 regulated proliferation and apoptosis of human lung carcinoma cells by the Wnt/β-catenin signaling pathway Y.-Z. Guo, X.-L. Xie, J. Fu, G.-L. Xing Free PDF Download
Eur Rev Med Pharmacol Sci 2018; 22 (15): 4888-4897DOI: 10.26355/eurrev_201808_15625 MiR-1269a acts as an onco-miRNA in non-small cell lung cancer via down-regulating SOX6 R.-H. Jin, D.-J. Yu, M. Zhong Free PDF Download
Eur Rev Med Pharmacol Sci 2018; 22 (15): 4879-4887DOI: 10.26355/eurrev_201808_15624 LncRNA NNT-AS1 is a major mediator of cisplatin chemoresistance in non-small cell lung cancer through MAPK/Slug pathway Y. Cai, Z.-Y. Dong, J.-Y. Wang Free PDF Download
Eur Rev Med Pharmacol Sci 2018; 22 (15): 4869-4878DOI: 10.26355/eurrev_201808_15623 MiR-5692a promotes the invasion and metastasis of hepatocellular carcinoma via MMP9 S.-J. Sun, N. Wang, Z.-W. Sun, J. Chen, H.-W. Cui Free PDF Download